Medical travel to India: an honest overview

Most overviews of medical travel to India are written to sell it. They lead with the size of the market and the size of the saving, and they stop there. Both of those things are true and neither of them tells you whether you, specifically, should get on a plane.

This is a plainer account. It covers who actually comes, what they come for, what India genuinely does well, and — the part the sales pages skip — the four ways these journeys most often go wrong. We arrange this travel, so treat the optimistic parts with appropriate suspicion; the useful section is the one about failure.

Who actually travels to India for treatment?

The scale is large. One widely cited figure puts international patients treated in India at {{500,000 — source needed}} in a recent year, around {{5.5% — source needed}} of all foreign arrivals, with the market valued at roughly {{$8.7 billion — source needed}} and projected to grow toward {{$16.2 billion — source needed}} at a forecast {{12.4% CAGR — source needed}}. Every one of those numbers needs a primary citation before it should be relied on, but the order of magnitude is not in doubt.

The composition matters more than the total. The largest flows have historically come from neighbouring and regional countries — figures cited include {{Bangladesh 325,127 — source needed}}, {{Iraq 30,989 — source needed}}, {{Uzbekistan 13,699 — source needed}}, {{Somalia 11,506 — source needed}} and {{Oman 9,738 — source needed}} patients. Patients from the US, UK, Australia and Canada are a smaller but growing segment, usually weighing elective or complex procedures against high home costs or long waits.

What do people come for?

Broadly, three things. Complex surgery where the cost gap is largest — cardiac, orthopaedic and oncological procedures in particular; elective surgery that carries a long wait at home, which is the main driver from the UK and Canada; and second opinions, where the question is whether a diagnosis or a proposed operation is right before any travel is contemplated at all. That last category often ends without a flight, which is rather the point of it.

What genuinely works well

Three things hold up under scrutiny. The cost gap for major surgery is real and, for open-heart procedures, an order of magnitude — we set out the numbers, with every figure flagged, in cardiac surgery costs: India compared with the US, UK and Australia. The clinical workforce is deep: India trains a very large number of doctors each year — one figure cited is {{80,000 doctors annually — source needed}} — and many senior specialists trained abroad before returning to lead high-volume departments. And English is the working language of Indian medicine, so clinical conversations usually happen directly rather than through an interpreter.

Accreditation is the fourth thing worth checking, with a caveat. One figure puts India at {{839 NABH-accredited hospitals — source needed}}, and a number additionally hold JCI accreditation. Accreditation certifies process, not a surgeon's individual results — we explain the distinction in JCI and NABH accreditation: what each one actually certifies.

The four failure modes behind most bad experiences

When a medical-travel journey goes badly, it is rarely because the surgery itself failed. It is almost always one of these four, and all four are avoidable.

1. The price changes after you land. This is the most common and the most preventable. A patient is given an "all-inclusive" estimate {{CONFLICT: site quotes a single binding figure after clinical review, not a price-list estimate — confirm}}, or a "free personalised estimate within 24 hours" {{CONFLICT: site quotes a single binding figure after clinical review, not a price-list estimate — confirm}}, treats it as a quote, and discovers at the discharge desk that it was neither binding nor complete. An indicative estimate is not a quote. The difference, and the exact wording to look for, is the subject of what to ask every facilitator about cost overruns.

2. No plan for follow-up at home. A knee replacement is largely finished when you walk out; chemotherapy, immunosuppression, or a device needing regular checks is not. If nobody at home has agreed to manage the aftercare, treatment abroad can be technically successful and still go badly. Establish a named clinician who will take it on before you fly.

3. Complications on or after the return flight. Long-haul travel soon after major surgery carries real risk. A complication managed in the hospital that caused it is an inconvenience; the same event three days after landing, presenting to a team with no operative notes, is a different problem. This is one reason we advise against travel in some cases entirely — set out in when you should not travel to India for treatment.

4. Travelling alone. Post-operative patients need an advocate — someone to notice they are not right, hold the discharge summary, and decide for them if they cannot. Hospitals are staffed; they are not a substitute for a person whose only job is you. If you cannot travel with a companion for the admission period, major surgery abroad is harder to justify.

Is it the right decision for you?

Sometimes clearly yes — a large, well-understood procedure, a binding quote, a named coordinator, a companion, and a doctor at home ready to pick up the follow-up. Sometimes clearly no. And often the honest first step is not travel at all but a written second opinion on whether the treatment is even the right one. If you do decide to go, the things to get right are unglamorous and specific — a binding price, a plan for the flight home, and a written answer to who pays if the cost overruns.